Company Overview and News

 
Troy Resources achieves record gold production for quarter

2018-04-08 australianmining.com.au
Troy Resources’ Guyanese gold operation Karouni has achieved a company record of 21,703 ounces (oz) of gold production for the quarter ending March 2018.
Upvote Downvote

 
Tyranna Resources eyes producer status at Eureka Gold Project

2018-01-18 proactiveinvestors.com.au
Tyranna Resources Ltd (ASX:TYX) aims to transition from explorer to producer through its recently acquired Eureka Gold Mine located north of Kalgoorlie in Western Australia.
Upvote Downvote

 
Troy Resources calls halt pending outcome of board spill

2017-10-09 proactiveinvestors.com.au
Troy Resources Ltd (ASX:TRY) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open.
Upvote Downvote

 
Troy shareholder calls for board spill

2017-08-15 businessnews.com.au
A Singaporean group that holds about a 5 per cent stake in Troy Resources has called for a meeting to seek the replacement of the gold miner’s board members with its own nominees.
Upvote Downvote

 
Anfield Gold Announces Positive Feasibility Results at its Coringa Project

2017-07-25 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 25, 2017) - Anfield Gold Corp. ("Anfield" or the "Company") (TSX VENTURE:ANF) announces the results of the Feasibility Study (the "Study"), prepared in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects ("NI 43-101"), for its 100%-owned Coringa Project ("Coringa" or the "Project"). The Study was compiled by MTB Project Management Professionals Inc.
Upvote Downvote

 
Sandspring Resources For Deep Value Investors In Gold

2017-07-21 seekingalpha
Sandspring Resources is an out-of-the-money call option on gold with a $1,300 strike price and no expiration date.
Upvote Downvote

 
Anfield Announces an Updated NI 43-101 Mineral Resource Estimate for its Coringa Project

2017-05-03 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 3, 2017) - Anfield Gold Corp. ("Anfield" or "Company") (TSX VENTURE:ANF) has completed an updated mineral resource estimate on its Coringa Project ("Coringa" or "Project") located in the Para State of Brazil. The updated mineral resource estimate is based on approximately 25,200 metres of infill drilling, which concluded in March 2017, and prior drilling completed by Magellan Minerals (which was acquired by Anfield in 2016).
Upvote Downvote

 
Purvis leaves Troy for top MZI role

2017-05-03 businessnews.com.au
Martin Purvis has announced he is leaving his post as managing director and chief executive of Troy Resources to take on the same responsibilities at mineral sands miner MZI Resources, following Trevor Matthews’ resignation in November.
Upvote Downvote

 
Austral Gold Reports Third Fiscal Quarter 2017 Results

2017-04-28 accesswire
VANCOUVER, BC / ACCESSWIRE / April 28, 2017 / Austral Gold Limited ("the Company") (ASX: AGD) (TSXV: AGLD) (OTC PINK: AGLDF) is pleased to report results for quarterly activities for its third fiscal quarter ended March 31, 2017.
Upvote Downvote

 
Austral Gold Acquires a Further 19% of Casposo Mine

2017-03-06 accesswire
VANCOUVER, BC / ACCESSWIRE / March 6, 2017 / Austral Gold Limited (ASX: AGD) (TSXV: AGLD) ('Austral' or 'the Company') is pleased to announce that the Company has paid US$1 million to Troy Resources Limited ('Troy') (ASX: TRY) to acquire an additional 19% interest in the Casposo silver-gold mine located in San Juan, Argentina ('Casposo').
Upvote Downvote

 
Anfield Provides Progress Update on the Coringa Project

2017-02-21 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 21, 2017) - Anfield Gold Corp. ("Anfield" or the "Company") (TSX VENTURE:ANF) is pleased to report on progress at its 100% owned Coringa Gold Project (the "Project") in Para State, Brazil.
Upvote Downvote

 
Austral Gold Reports Second Fiscal Quarter 2017 Results

2017-02-03 accesswire
VANCOUVER, BC / ACCESSWIRE / February 3, 2017 / Austral Gold Limited ('the Company') (ASX: AGD) (TSXV: AGLD) is pleased to report results for quarterly activities for its second fiscal quarter ended December 31, 2016.
Upvote Downvote

 
Tiny South American Nation Hits Record Gold Production - ValueWalk

2017-01-02 valuewalk
Big resource developments from a tiny and unexpected nation this week. Where both the mining and energy sectors are, incredibly, taking off at the same time.
Upvote Downvote

 
Guyana reports record gold production of 700,000 troy ounces

2016-12-10 nzherald.co.nz
GEORGETOWN, Guyana (AP) " Officials in Guyana say the South American nation will post record gold production this year.
Upvote Downvote

 
Tajiri Resources Corp.: Drilling within 2 weeks at the Company's Kaburi Gold Project, Guyana

2016-11-23 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 23, 2016) - Tajiri Resources Corp. (the "Company") (TSX VENTURE:TAJ) is pleased to announce that it will continue exploration at the Kaburi Project with diamond drilling at the Gussie prospect starting within 2 weeks and first results expected in January 2017.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...